Cannabis Use and Psychosis: Current Perspectives

被引：0

作者：

Grenier, Ernesto ^{[1
]}

Ryan, Molly ^{[1
]}

Mithani, Zain ^{[2
]}

Junquera, Patricia ^{[2
]}

机构：

[1] Univ Miami, Dept Psychiat & Behav Sci, Jackson Mem Hosp, 1695 NW 9 Ave,Suite 3100, Miami, FL 33136 USA

[2] Univ Miami, Leonard Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL USA

来源：

ADDICTIVE DISORDERS & THEIR TREATMENT | 2013年 / 12卷 / 03期

关键词：

cannabis; schizophrenia; psychosis;

D O I：

10.1097/ADT.0b013e3182624271

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Cannabis is the most commonly abused illicit drug in the United States. Its use, however, is not without its dangers. Mounting evidence has recently shown a possible link between cannabis use and the development of psychosis and a subsequent predisposition to developing schizophrenia. In this article, the authors review the literature related with cannabis use and the appearance of a psychotic disorder, data supporting the existence of cannabis-induced psychosis and the association between cannabis and schizophrenia along with the case of an 18-year-old white man with a severe cannabis dependence who developed schizophrenia-like symptoms.

引用

页码：136 / 139

页数：4

共 16 条

[1] Cannabis and schizophrenia:: impact on onset, course, psychopathology and outcomes [J].

Bersani, G ;

Orlandi, V ;

Kotzalidis, GD ;

Pancheri, P .

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2002, 252 (02) :86-92

[2] Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction [J].

Caspi, A ;

Moffitt, TE ;

Cannon, M ;

McClay, J ;

Murray, R ;

Harrington, H ;

Taylor, A ;

Arseneault, L ;

Williams, B ;

Braithwaite, A ;

Poulton, R ;

Craig, IW .

BIOLOGICAL PSYCHIATRY, 2005, 57 (10) :1117-1127

[3] A neurobiological basis for substance abuse comorbidity in schizophrenia [J].

Chambers, RA ;

Krystal, JH ;

Self, DW .

BIOLOGICAL PSYCHIATRY, 2001, 50 (02) :71-83

[4] Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample [J].

Compton, MT ;

Furman, AC ;

Kaslow, NJ .

SCHIZOPHRENIA RESEARCH, 2004, 71 (01) :61-64

[5] Cannabinoids & psychosis: Evidence from studies with I.V THC in schizophrenic patients and controls [J].

D'Souza, DC ;

Abi-Saab, W ;

Madonick, S ;

Wray, Y ;

Forselius, K ;

MacDougall, L ;

Brush, L ;

Cassello, K ;

Krystal, J .

SCHIZOPHRENIA RESEARCH, 2000, 41 (01) :33-33

[6] Studies on [3H]CP-55940 binding in the human central nervous system:: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use [J].

Dean, B ;

Sundram, S ;

Bradbury, R ;

Scarr, E ;

Copolov, D .

NEUROSCIENCE, 2001, 103 (01) :9-15

[7] Dopamine activation of endogenous cannabinoid signaling in dorsal striatum [J].

Giuffrida, A ;

Parsons, LH ;

Kerr, TM ;

de Fonseca, FR ;

Navarro, M ;

Piomelli, D .

NATURE NEUROSCIENCE, 1999, 2 (04) :358-363

[8]

Hall W, 2010, ANZ J PSYCHIAT, V34, P26

[9] Psychosis reactivity to cannabis use in daily life: an experience sampling study [J].

Henquet, Cecile ;

van Os, Jim ;

Kuepper, Rebecca ;

Delespaul, Philippe ;

Smits, Maurice ;

Campo, Joost A. ;

Myin-Germeys, Inez .

BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (06) :447-453

[10] Elevated endogenous cannabinoids in schizophrenia [J].

Leweke, FM ;

Giuffrida, A ;

Wurster, U ;

Emrich, HM ;

Piomelli, D .

NEUROREPORT, 1999, 10 (08) :1665-1669

← 1 2 →